NTRB
NTRB
NASDAQ · Pharmaceuticals

Nutriband Inc

$3.83
+0.08 (+2.13%)
As of Mar 25, 4:50 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +801.0% upside
Low Target $26.32
Average Target $34.51
High Target $56.88
Current Price $3.83
Current
$3.83
Target
$34.51
$26.32 $34.51 avg $56.88
Scenario Analysis
Bear Case
$26.32
587.2%
Low target
Base Case
$34.51
+801.0%
Avg target
Bull Case
$56.88
+1,385.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$11.68
-67.2% from high
52-Week Low
$3.64
+5.4% from low
Target vs 52W High
$34.51
+195.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%